Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Military Report Slams DMAA While GNC Claims Victory

This article was originally published in The Tan Sheet

Executive Summary

A Department of Defense safety review panel does not find a conclusive causal association between DMAA and adverse events, including four service members’ deaths, a conclusion that “delighted” retailer GNC. But DoD’s ban on sales of DMAA products in military exchanges and concessions remains in place.

Advertisement

Related Content

NSF ‘Certified For Sport’ Apps Cuts Through Unsafe Supplement Clutter
DMAA, Other Stimulants Cast Shadow Over FDA Supplement Regulation – Study
FTC Shares Doubts About Supplements, Ad Claims In Its Consumer Library
DMAA Supplement Direct Seller Ceases Operations Under Consent Decree
GNC Supply Chain Reform Pays Dividends In DoJ Settlement From DMAA Investigation
Industry Roundup: USPlabs Cleared In DMAA Suit, AHPA Opposes Blueberry Extract Tariff Hike
In Brief
FDA Using “All Available Tools” To Remove DMAA From Market
DMAA Supplements Banned In U.K., Hamstrung In U.S.
U.S. Military Investigates Supplement Ingredient DMAA, Bans Sales

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106552

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel